MGC Pharmaceuticals Ltd
ASX:MXC

Watchlist Manager
MGC Pharmaceuticals Ltd Logo
MGC Pharmaceuticals Ltd
ASX:MXC
Watchlist
Price: 0.415 AUD Market Closed
Market Cap: 18.2m AUD

Intrinsic Value

MXC doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of MXC.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MXC Intrinsic Value
Not Available
Base Case Scenario
Compare MXC to

Fundamental Analysis

MGC Pharmaceuticals Ltd
ASX:MXC
AU
Pharmaceuticals
Market Cap
18.2m AUD
IPO
Dec 21, 2006
AU
Pharmaceuticals
Market Cap
18.2m AUD
IPO
Dec 21, 2006
Price
AU$false
EPS
AU$false
Company Overview
Loading...
Contacts
Loading...
How do you feel about MXC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about MGC Pharmaceuticals Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
MGC Pharmaceuticals Ltd

Current Assets 9.4m
Cash & Short-Term Investments 6.5m
Receivables 531.3k
Other Current Assets 2.4m
Non-Current Assets 8m
Long-Term Investments 1.3m
PP&E 6.7m
Efficiency

Free Cash Flow Analysis
MGC Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
MGC Pharmaceuticals Ltd

Revenue
1.3m AUD
Cost of Revenue
-1m AUD
Gross Profit
289.6k AUD
Operating Expenses
-15.8m AUD
Operating Income
-15.5m AUD
Other Expenses
-1.5m AUD
Net Income
-17m AUD
Fundamental Scores

MXC Profitability Score
Profitability Due Diligence

MGC Pharmaceuticals Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROE is Increasing
Sustainable 3Y Average Gross Margin
37/100
Profitability
Score

MGC Pharmaceuticals Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

MXC Solvency Score
Solvency Due Diligence

MGC Pharmaceuticals Ltd's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
39/100
Solvency
Score

MGC Pharmaceuticals Ltd's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MXC Price Targets Summary
MGC Pharmaceuticals Ltd

There are no price targets for MXC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

MGC Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for MXC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y